权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Structure and Function of GABA-A receptors

GABA-A 受体的结构和功能

基本信息

批准号：
10827752
负责人：
Ryan E Hibbs
金额：
$ 33.92万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN DIEGO
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-02-01 至 2024-09-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10827752
关键词：
Address Agonist Amino Acids Anesthetics Antibodies Anxiety Anxiety Disorders Architecture Barbiturates Behavior Benzodiazepines Binding Binding Sites Brain Cell Surface Receptors Central Nervous System Chemicals Chemosensitization Chloride Channels Complement Complement 2 Complex Cryoelectron Microscopy Data Data Set Diazepam Disease Drug Targeting Electrophysiology (science)Environment Epilepsy Epitopes Equilibrium Ethanol Extracellular Domain Flumazenil Functional disorder GABA Agonists GABA-A Receptor General anesthetic drugs Isoflurane Ligands Lipids Membrane Midazolam Modeling Molecular Monitor Mutagenesis Mutate Nervous System Nervous System Physiology Neurotransmitter Receptor Neurotransmitters Pentobarbital Pharmaceutical Preparations Pharmacology Physiological Postsynaptic Membrane Preparation Propofol Protein Isoforms Proteins Publishing Recombinants Research Resolution Side Signal Transduction Site Sleeplessness Structure Sum Synapses Therapeutic Transmembrane Domain Work antagonist drug mechanism drug of abuse excitotoxicity experimental study extracellular fascinate gamma-Aminobutyric Acid improved nanodisk neurosteroids positive allosteric modulator receptor reconstitution reconstruction therapeutic target

项目摘要

The GABA-A receptor is the most abundant inhibitory neurotransmitter receptor in the central nervous system and is the target of myriad therapeutic compounds and drugs of abuse. Function of the nervous system is governed by a balance of excitatory and inhibitory signaling; GABA-A receptor dysfunction results in disorders of anxiety and excitotoxicity including epilepsy. The principal isoform of this pentameric ligand-gated chloride channel is found on post-synaptic membranes in the brain. GABA (γ-aminobutyric acid) is the endogenous neurotransmitter and agonist of this receptor. Benzodiazepines, like diazepam (Valium) and midazolam (Versed), are positive allosteric modulators taken by 5% of the US for anxiety and insomnia. Barbiturates like pentobarbital, anesthetics like isoflurane and propofol, neurosteroids, and ethanol are all positive modulators acting through non-overlapping sites. This rich pharmacology derives from the complex subunit assembly of the synaptic GABA-A receptor. The predominant synaptic isoform consists of two α1 subunits, two β2 subunits and one γ2 subunit. Here we propose to address a lack of structural information on physiological GABA-A receptors using a direct approach. In three Specific Aims, we propose to elucidate the structural mechanism of benzodiazepine potentiation of these receptors, perform complementary electrophysiological experiments on the recombinant receptor, and in parallel characterize the structural principles underlying modulation by barbiturates, anesthetics and neurosteroids. The two structural Aims are independent and will yield fundamentally new and distinct structural information for the principal GABA-A receptor type in the central nervous system in complex with extracellular and transmembrane-site ligands. The functional Aim complements the structural work to define determinants for benzodiazepine binding, efficacy and allosteric signaling. The sum of structures and function will illuminate principles defining heteromer assembly and ligand recognition and will elucidate how drug binding changes molecular behavior, with broad relevance across the Cys-loop receptor superfamily.

GABA-A受体是中枢神经中最丰富的抑制性神经递质受体